Stanford University
Showing 1,621-1,640 of 2,432 Results
-
KT Park MD MS
Adjunct Professor, Medicine - Med/Gastroenterology and Hepatology
BioPrior to joining Genentech in 2018, Dr. Park was Associate Professor at Stanford University School of Medicine, Co-Director of the IBD Center at Stanford Children’s Health, and an expert in Crohn’s disease and ulcerative colitis. Currently, he is the Global Head of Gastroenterology, Hepatology & Metabolism in Product Development at Genentech and Roche. Trained as a health economist, during his tenure in academia, Dr Park held research grants and funding support focused on the cost-effectiveness of biologic treatment strategies and novel non-invasive biomarkers for children and adults with IBD. He led national research registries at the Crohn’s & Colitis Foundation and scientific/clinical committees in numerous GI societies and physicians’ organizations. He received his BA in chemistry/biochemistry at Duke University, MD at University of Tennessee, and MSc in Health Economics/Policy at Stanford where he completed his clinical and postdoctoral trainings. He is Adjunct Professor of Medicine in the Division of Gastroenterology & Hepatology at Stanford University. At Genentech Roche, Dr. Park directs a team of clinical scientists and medical directors overseeing clinical phase drug development in gastroenterology, hepatology, and metabolism.
-
Walter Park
Professor of Medicine (Gastroenterology and Hepatology)
Current Research and Scholarly InterestsDr. Park's research interests are in the diagnosis and management of pancreatic cysts, acute and chronic pancreatitis. His approach incorporates methods in health services research including the use of observational datasets, cost-effectiveness studies, and the development of clinical cohorts.
-
Jane Parnes
Professor of Medicine, Emerita
Current Research and Scholarly InterestsThe lab is studying the mechanisms controlling B cell responsiveness and the balance between tolerance and autoimmunity. B cells deficient in CD72 are hyperresponsive to stimulation through the B cell receptor. We are examining the alterations in B cell signaling in these B cells and the mechanisms by which CD72 deficiency partially abrogates anergic tolerance. We hope to learn how deficiency in CD72 leads to spontaneous autoimmunity and increased susceptibility to induced autoimmune disease.
-
Julie Parsonnet
George DeForest Barnett Professor of Medicine, Emerita
Current Research and Scholarly InterestsI am an infectious diseases epidemiologist who has done large field studies in both the US and developing countries. We research the long-term consequences of chronic interactions between the human host and the microbial world. My lab has done fundamental work establishing the role of H. pylori in causing disease and understanding its epidemiology. Currently, our research dissects how and when children first encounter microbes and the long term effects of these exposures on health.
-
Gopanandan Parthasarathy
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioDr Nandan Parthasarathy is a hepatologist and physician-scientist in the Department of Gastroenterology and Hepatology at Stanford University.
After obtaining his medical degree in JIPMER, India, he completed a 2 year clinical research fellowship at Mayo Clinic, following which he completed his residency training at Cleveland Clinic, and GI and transplant hepatology fellowships at Mayo Clinic. During his fellowship, his research work was focused on exploring the immune mechanisms of liver injury in metabolic dysfunction associated steatohepatitis.
Clinically, he is focused on taking care of patients with MASH, cirrhosis and liver cancer.
His career goal is to study the gut-immune system-liver injury axis in order to bring novel therapeutics from the bench to bedside in patients with liver disease. -
Michele Lanpher Patel
Instructor, Medicine - Stanford Prevention Research Center
BioMichele ("Shelley") L. Patel, PhD is an Instructor in the Stanford Prevention Research Center at the Stanford University School of Medicine. Trained as a clinical health psychologist, Dr. Patel conducts research to optimize scalable digital health interventions for adults with obesity. She leads clinical trials that test innovative strategies to promote weight loss, dietary quality, physical activity, and engagement in digital health interventions.
Supported by an NIH career development award (K23), Dr. Patel's Spark trial investigated the most potent combination of self-monitoring strategies in a behavioral weight loss intervention among 176 adults with overweight or obesity. Further, Dr. Patel's NIH-funded R01 (2026-2031) will test a simplified vs. detailed dietary self-monitoring strategy for improving engagement and weight loss in a scalable digital intervention.
Her work leverages the Multiphase Optimization Strategy (MOST) to systematically identify intervention strategies that maximize the effectiveness of a digital health intervention while minimizing patient burden. Recent work has focused on topics like whether to assign easier vs. harder goals and which combination of low-friction dietary strategies enhance success.
Dr. Patel received her PhD in clinical psychology from Duke University. She completed her clinical internship at the VA Palo Alto with a specialization in behavioral medicine, followed by a postdoctoral fellowship (T32) at the Stanford Prevention Research Center. She currently serves as the Past Chair of the Optimization of Behavioral and Biobehavioral Interventions special interest group in the Society of Behavioral Medicine.
Primary Research Interests:
-- Optimizing scalable digital interventions for obesity treatment and prevention
-- Leveraging behavioral science to create lower-burden self-monitoring strategies to improve engagement and outcomes
-- Identifying psychosocial factors (including health literacy and self-efficacy) that influence treatment success
Methodological Expertise:
-- Randomized clinical trials, including factorial designs and embedded trials
-- Systematic reviews
-- Signal detection analysis
*New 2026 paper on goal setting in a digital weight loss intervention: https://onlinelibrary.wiley.com/doi/10.1002/osp4.70175 -
Neev Patel
Affiliate, Department Professorship Funds
Fellow in Medicine - Med/Pulmonary, Allergy & Critical Care MedicineCurrent Research and Scholarly InterestsPoint-of-care echocardiography applied to hemodynamic questions in critical care nephrology. Current work examines echocardiographic predictors of vasoconstrictor response in hepatorenal syndrome, through the HRS Harmony Consortium working group he leads; the left ventricular velocity-time integral as a portable measure of stroke volume in the Project Baseline and WASE cohorts; and right ventricular measures for classifying pulmonary hypertension.
-
Neha Patel, MD
Clinical Assistant Professor, Medicine - Oncology
BioDr. Neha Patel is a triple board-certified, fellowship-trained medical oncologist with Stanford Health Care. She is also a clinical assistant professor in the Department of Medicine, Division of Oncology at Stanford University School of Medicine.
Dr. Patel provides expert, personalized care for patients with both common and rare cancers and specializes in treating patients with genitourinary cancer. She is deeply committed to delivering comprehensive, patient-centered oncology services, with an emphasis on helping individuals and their families understand their diagnosis and navigate treatment options with confidence and clarity.
Her research focuses on designing and implementing system-level interventions to advance equitable, high-value cancer care. Dr. Patel is particularly passionate about integrating oncology and palliative (symptom-relieving) care—creating collaborative models that improve patient outcomes, elevate the quality of life, and enhance the overall care experience.
Known for her compassionate and relational approach, Dr. Patel builds strong, trusting partnerships with the patients and families she serves. She prioritizes care that aligns with each individual’s values, preferences, and goals, with the aim of achieving the best possible quality of life and longevity.
